id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-2390-0097,FDA,FDA-2022-N-2390,Exhibit 208,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:54Z,,0,0,09000064868a2ef0
FDA-2022-N-2390-0128,FDA,FDA-2022-N-2390,Exhibit 239,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:26Z,,0,0,09000064868a2f37
FDA-2022-N-2390-0123,FDA,FDA-2022-N-2390,Exhibit 234,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:56Z,,0,0,09000064868a2f32
FDA-2022-N-2390-0126,FDA,FDA-2022-N-2390,Exhibit 237,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:37Z,,0,0,09000064868a2f35
FDA-2022-N-2390-0090,FDA,FDA-2022-N-2390,Exhibit 201,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:04Z,,0,0,09000064868a2ee9
FDA-2022-N-2390-0096,FDA,FDA-2022-N-2390,Exhibit 207,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:48Z,,0,0,09000064868a2eef
FDA-2022-N-2390-0127,FDA,FDA-2022-N-2390,Exhibit 238,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:31Z,,0,0,09000064868a2f36
FDA-2022-N-2390-0088,FDA,FDA-2022-N-2390,Exhibit 199,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:28:52Z,,0,0,09000064868a3103
FDA-2022-N-2390-0103,FDA,FDA-2022-N-2390,Exhibit 214,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:27Z,,0,0,09000064868a2f07
FDA-2022-N-2390-0115,FDA,FDA-2022-N-2390,Exhibit 226,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:14Z,,0,0,09000064868a2f1d
FDA-2022-N-2390-0101,FDA,FDA-2022-N-2390,Exhibit 212,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:37Z,,0,0,09000064868a2f05
FDA-2022-N-2390-0107,FDA,FDA-2022-N-2390,Exhibit 218,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:05Z,,0,0,09000064868a2f0b
FDA-2022-N-2390-0120,FDA,FDA-2022-N-2390,Exhibit 231,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:47Z,,0,0,09000064868a2f2f
FDA-2024-H-5929-0001,FDA,FDA-2024-H-5929,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T14:32:14Z,,0,0,090000648689709d
FDA-2000-N-0011-0028,FDA,FDA-2000-N-0011,Uniform Compliance Date for Food Labeling Regulations,Rule,Final Rule,2024-12-31T05:00:00Z,2024,12,2024-12-31T05:00:00Z,2025-03-04T04:59:59Z,2025-03-05T02:00:44Z,2024-31419,0,0,0900006486896c8a
FDA-2024-N-3271-0002,FDA,FDA-2024-N-3271,Flamingo Pharmaceuticals Ltd.; Withdrawal of Approval of Two Abbreviated New Drug Applications,Notice,Withdrawal,2024-12-31T05:00:00Z,2024,12,2024-12-31T05:00:00Z,,2024-12-31T14:36:36Z,2024-31360,0,0,0900006486896c82
FDA-2024-H-5921-0001,FDA,FDA-2024-H-5921,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2024-12-31T05:00:00Z,,2024-12-31T16:08:58Z,,0,0,090000648689712d
FDA-2022-N-2390-0105,FDA,FDA-2022-N-2390,Exhibit 216,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:18Z,,0,0,09000064868a2f09
FDA-2022-N-2390-0106,FDA,FDA-2022-N-2390,Exhibit 217,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:11Z,,0,0,09000064868a2f0a
FDA-2022-N-2390-0111,FDA,FDA-2022-N-2390,Exhibit 222,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:39Z,,0,0,09000064868a2f19
FDA-2022-N-2390-0113,FDA,FDA-2022-N-2390,Exhibit 224,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:26Z,,0,0,09000064868a2f1b
FDA-2022-N-2390-0079,FDA,FDA-2022-N-2390,Exhibit 190,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:27:08Z,,0,0,09000064868a27cf
FDA-2022-N-2390-0084,FDA,FDA-2022-N-2390,Exhibit 195,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:28:11Z,,0,0,09000064868a28ff
FDA-2022-N-2390-0098,FDA,FDA-2022-N-2390,Exhibit 209,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:59Z,,0,0,09000064868a2ef1
FDA-2022-N-2390-0074,FDA,FDA-2022-N-2390,Index to Exhibits,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:25:42Z,,0,0,09000064868a4593
FDA-2022-N-2390-0080,FDA,FDA-2022-N-2390,Exhibit 191,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:27:13Z,,0,0,09000064868a28fb
FDA-2024-H-5925-0001,FDA,FDA-2024-H-5925,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T14:58:24Z,,0,0,090000648689756a
FDA-2024-H-5800-0001,FDA,FDA-2024-H-5800,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T15:04:04Z,,0,0,0900006486898448
FDA-2024-H-5916-0001,FDA,FDA-2024-H-5916,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T15:11:03Z,,0,0,0900006486898d43
FDA-2024-H-5928-0001,FDA,FDA-2024-H-5928,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T14:04:26Z,,0,0,0900006486897071
FDA-2024-H-5920-0001,FDA,FDA-2024-H-5920,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2024-12-31T05:00:00Z,,2024-12-31T15:13:15Z,,0,0,09000064868968ce
FDA-2024-H-5922-0001,FDA,FDA-2024-H-5922,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2024-12-31T05:00:00Z,,2024-12-31T15:54:19Z,,0,0,0900006486897104
FDA-2024-N-2980-0006,FDA,FDA-2024-N-2980,"Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-On Recombinant Peptide Products;
Reopening of the Comment Period",Notice,Extension of Comment Period,2024-12-31T05:00:00Z,2024,12,2024-12-31T05:00:00Z,,2024-12-31T14:48:35Z,2024-31365,0,0,0900006486896ad4
FDA-2024-H-5924-0001,FDA,FDA-2024-H-5924,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T14:57:26Z,,0,0,090000648689754d
FDA-2022-N-2390-0085,FDA,FDA-2022-N-2390,Exhibit 196,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:28:17Z,,0,0,09000064868a3100
FDA-2022-N-2390-0100,FDA,FDA-2022-N-2390,Exhibit 211,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:11Z,,0,0,09000064868a2f04
FDA-2022-N-2390-0102,FDA,FDA-2022-N-2390,Exhibit 213,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:32Z,,0,0,09000064868a2f06
FDA-2022-N-2390-0104,FDA,FDA-2022-N-2390,Exhibit 215,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:23Z,,0,0,09000064868a2f08
FDA-2022-N-2390-0112,FDA,FDA-2022-N-2390,Exhibit 223,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:32Z,,0,0,09000064868a2f1a
FDA-2022-N-2390-0114,FDA,FDA-2022-N-2390,Exhibit 225,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:20Z,,0,0,09000064868a2f1c
FDA-2022-N-2390-0117,FDA,FDA-2022-N-2390,Exhibit 228,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:03Z,,0,0,09000064868a2f1f
FDA-2024-H-5931-0001,FDA,FDA-2024-H-5931,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T14:48:56Z,,0,0,09000064868971c7
FDA-2024-H-5917-0001,FDA,FDA-2024-H-5917,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T15:11:54Z,,0,0,0900006486898d49
FDA-2022-N-2390-0083,FDA,FDA-2022-N-2390,Exhibit 194,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:27:40Z,,0,0,09000064868a28fe
FDA-2022-N-2390-0094,FDA,FDA-2022-N-2390,Exhibit 205,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:37Z,,0,0,09000064868a2eed
FDA-2022-N-2390-0089,FDA,FDA-2022-N-2390,Exhibit 200,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:28:58Z,,0,0,09000064868a3104
FDA-2022-N-2390-0075,FDA,FDA-2022-N-2390,Exhibit 186,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:25:49Z,,0,0,09000064868a27cb
FDA-2022-N-2390-0076,FDA,FDA-2022-N-2390,Exhibit 187,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:25:55Z,,0,0,09000064868a27cc
FDA-2022-N-2390-0099,FDA,FDA-2022-N-2390,Exhibit 210,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:05Z,,0,0,09000064868a2ef2
FDA-2022-N-2390-0124,FDA,FDA-2022-N-2390,Exhibit 235,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:49Z,,0,0,09000064868a2f33
FDA-2022-N-2390-0122,FDA,FDA-2022-N-2390,Exhibit 233,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:36Z,,0,0,09000064868a2f31
FDA-2022-N-2390-0109,FDA,FDA-2022-N-2390,Exhibit 220,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:53Z,,0,0,09000064868a2f0d
FDA-2024-H-5918-0001,FDA,FDA-2024-H-5918,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2024-12-31T05:00:00Z,,2024-12-31T14:00:47Z,,0,0,090000648689688b
FDA-2024-H-5867-0001,FDA,FDA-2024-H-5867,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2024-12-31T05:00:00Z,,2024-12-31T14:43:58Z,,0,0,09000064868968a8
FDA-2024-N-5830-0001,FDA,FDA-2024-N-5830,Advisory Committee; Dermatologic and Ophthalmic Drugs Advisory Committee; Renewal,Notice,Notice of Renewal,2024-12-31T05:00:00Z,2024,12,2024-12-31T05:00:00Z,,2024-12-31T14:00:03Z,2024-31363,0,0,0900006486896cc5
FDA-2024-H-5926-0001,FDA,FDA-2024-H-5926,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T14:59:14Z,,0,0,090000648689758c
FDA-2024-H-5915-0001,FDA,FDA-2024-H-5915,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T15:09:09Z,,0,0,09000064868984fb
FDA-2024-H-5832-0001,FDA,FDA-2024-H-5832,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T15:07:02Z,,0,0,090000648689844e
FDA-2022-N-2390-0086,FDA,FDA-2022-N-2390,Exhibit 197,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:28:27Z,,0,0,09000064868a3101
FDA-2022-N-2390-0092,FDA,FDA-2022-N-2390,Exhibit 203,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:18Z,,0,0,09000064868a2eeb
FDA-2022-N-2390-0095,FDA,FDA-2022-N-2390,Exhibit 206,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:43Z,,0,0,09000064868a2eee
FDA-2022-N-2390-0129,FDA,FDA-2022-N-2390,Exhibit 240,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:19Z,,0,0,09000064868a2f38
FDA-2022-N-2390-0093,FDA,FDA-2022-N-2390,Exhibit 204,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:32Z,,0,0,09000064868a2eec
FDA-2022-N-2390-0116,FDA,FDA-2022-N-2390,Exhibit 227,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:09Z,,0,0,09000064868a2f1e
FDA-2022-N-2390-0118,FDA,FDA-2022-N-2390,Exhibit 229,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:57Z,,0,0,09000064868a2f20
FDA-2022-N-2390-0110,FDA,FDA-2022-N-2390,Exhibit 221,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:47Z,,0,0,09000064868a2f18
FDA-2022-N-2390-0121,FDA,FDA-2022-N-2390,Exhibit 232,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:41Z,,0,0,09000064868a2f30
FDA-2024-H-5923-0001,FDA,FDA-2024-H-5923,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2024-12-31T05:00:00Z,,2024-12-31T16:22:10Z,,0,0,0900006486897134
FDA-2024-H-5919-0001,FDA,FDA-2024-H-5919,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2024-12-31T05:00:00Z,,2024-12-31T15:50:42Z,,0,0,09000064868968fe
FDA-2024-H-5930-0001,FDA,FDA-2024-H-5930,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T14:33:28Z,,0,0,090000648689751e
FDA-2024-H-5914-0001,FDA,FDA-2024-H-5914,Complaint,Other,Complaint,2024-12-31T05:00:00Z,2024,12,2025-01-02T05:00:00Z,,2025-01-02T15:08:06Z,,0,0,0900006486898496
FDA-2022-N-2390-0078,FDA,FDA-2022-N-2390,Exhibit 189,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:07Z,,0,0,09000064868a27ce
FDA-2022-N-2390-0091,FDA,FDA-2022-N-2390,Exhibit 202,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:10Z,,0,0,09000064868a2eea
FDA-2022-N-2390-0125,FDA,FDA-2022-N-2390,Exhibit 236,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:43Z,,0,0,09000064868a2f34
FDA-2022-N-2390-0077,FDA,FDA-2022-N-2390,Exhibit 188,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:01Z,,0,0,09000064868a27cd
FDA-2022-N-2390-0081,FDA,FDA-2022-N-2390,Exhibit 192,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:27:20Z,,0,0,09000064868a28fc
FDA-2022-N-2390-0087,FDA,FDA-2022-N-2390,Exhibit 198,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:28:46Z,,0,0,09000064868a3102
FDA-2022-N-2390-0082,FDA,FDA-2022-N-2390,Exhibit 193,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:27:25Z,,0,0,09000064868a28fd
FDA-2022-N-2390-0119,FDA,FDA-2022-N-2390,Exhibit 230,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:51Z,,0,0,09000064868a2f21
FDA-2022-N-2390-0108,FDA,FDA-2022-N-2390,Exhibit 219,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:58Z,,0,0,09000064868a2f0c
FDA-2016-E-4588-0006,FDA,FDA-2016-E-4588,Determination of Regulatory Review Period for Purposes of Patent Extension; XTAMPZA ER,Notice,Determinations,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,2025-03-01T04:59:59Z,2025-02-24T02:00:23Z,2024-31023,0,0,0900006486894b77
FDA-2024-H-5887-0001,FDA,FDA-2024-H-5887,Complaint,Other,Complaint,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T15:16:52Z,,0,0,0900006486894a3c
FDA-2024-H-5897-0001,FDA,FDA-2024-H-5897,Complaint,Other,Complaint,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T15:21:32Z,,0,0,09000064868944b8
FDA-2023-N-4597-0003,FDA,FDA-2023-N-4597,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Shortages Data Collection,Notice,Notice of Approval,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T16:46:09Z,2024-31025,0,0,0900006486894ecc
FDA-2024-D-5580-0001,FDA,FDA-2024-D-5580,M15 General Principles for Model- Informed Drug Development; International Council for Harmonisation; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T16:48:34Z,2024-31027,0,0,0900006486894ec6
FDA-2024-N-3248-0002,FDA,FDA-2024-N-3248,"Fosun Pharma USA Inc., et al.; Withdrawal of Approval of 23 Abbreviated New Drug Applications; Correction",Notice,Correction,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T16:31:46Z,2024-31307,0,0,0900006486894fe2
FDA-2024-H-5901-0001,FDA,FDA-2024-H-5901,Complaint,Other,Complaint,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T18:42:02Z,,0,0,0900006486895a36
FDA-2023-D-5016-0002,FDA,FDA-2023-D-5016,"Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices; Guidance for Industry - Draft Guidance",Other,Guidance,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,2025-03-01T04:59:59Z,2025-10-16T09:00:23Z,,1,0,0900006486894c0f
FDA-2024-H-5904-0001,FDA,FDA-2024-H-5904,Complaint,Other,Complaint,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T21:07:38Z,,0,0,0900006486894bbe
FDA-2024-N-0008-0018,FDA,FDA-2024-N-0008,Request for Nominations for Individuals and Consumer Organizations for Advisory Committees,Notice,Request for Nominations,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T15:53:25Z,2024-31270,0,0,09000064868951c3
FDA-2024-N-5702-0001,FDA,FDA-2024-N-5702,"Transfer of Regulatory Responsibility From the Center for Devices and Radiological Health to the Center for
Biologics Evaluation and Research; Medical Maggots and Medicinal Leeches",Notice,Announcement,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T15:46:44Z,2024-31266,0,0,09000064868951c6
FDA-2024-N-0846-0003,FDA,FDA-2024-N-0846,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval;
National Agriculture and Food Defense Strategy Survey",Notice,Notice of Approval,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T15:00:00Z,2024-31298,0,0,090000648689526c
FDA-2024-E-0302-0008,FDA,FDA-2024-E-0302,Determination of Regulatory Review Period for Purposes of Patent Extension; VEOZAH,Notice,Determinations,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,2025-03-01T04:59:59Z,2024-12-30T17:41:51Z,2024-31269,0,0,0900006486894bff
FDA-2024-D-4490-0002,FDA,FDA-2024-D-4490,Combined FDA and Sponsor Oncologic Drugs Advisory Committee Briefing Document; Guidance for Industry - Draft Guidance,Other,Guidance,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,2025-03-01T04:59:59Z,2025-03-01T02:00:35Z,,1,0,09000064868954be
FDA-2024-H-5888-0001,FDA,FDA-2024-H-5888,Complaint,Other,Complaint,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T11:18:50Z,,0,0,09000064868916c3
FDA-2024-N-2149-0002,FDA,FDA-2024-N-2149,"Agency Information Collection Activities; Submission for Office of Management and Budget Review;
Comment Request; De Novo Classification Process (Evaluation of Automatic Class III Designation)",Notice,30 Day Proposed Information Collection,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,2025-01-30T04:59:59Z,2024-12-30T16:29:16Z,2024-31014,0,0,090000648689502a
FDA-2022-D-1562-0008,FDA,FDA-2022-D-1562,E11A Pediatric Extrapolation; Guidance for Industry,Other,Guidance,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T16:40:14Z,,1,0,0900006486895553
FDA-2024-H-5903-0001,FDA,FDA-2024-H-5903,Complaint,Other,Complaint,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T16:31:13Z,,0,0,09000064868944be
FDA-2024-H-5899-0001,FDA,FDA-2024-H-5899,Complaint,Other,Complaint,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T19:40:49Z,,0,0,0900006486895a7c
FDA-2024-E-0299-0008,FDA,FDA-2024-E-0299,Determination of Regulatory Review Period for Purposes of Patent Extension; VEOZAH,Notice,Determinations,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,2025-03-01T04:59:59Z,2024-12-30T17:37:48Z,2024-31269,0,0,0900006486894779